Clinical Trials Directory

Trials / Completed

CompletedNCT07076732

Beyond Platelet Indices, WBC-to-MPV Ratio in Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) Correlate With Short-Term Rather Than In-Hospital Outcomes

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the role of platelet indices and the \[White blood cell (WBC) /mean platelet volume (MPV)\] ratio in correlation with angiographic profiles of patients diagnosed with myocardial infarction with non-obstructive coronary arteries (MINOCA) to assess their predictive value for short-term clinical outcomes.

Detailed description

Globally, ischemic heart disease remains a significant cause of death, and its prevalence constantly increases. Around 5-15% of acute myocardial infarction (AMI) patients show nonobstructive (\<50% stenosis) coronary arteries, named myocardial infarction with nonobstructive coronary arteries (MINOCA). There are two main phases of inflammation during myocardial infarction: the inflammatory phase and the proliferative phase. The white blood cell (WBC) count and its subtypes have been investigated as potential predictors of cardiovascular outcomes in patients with coronary artery disease (CAD), serving as inflammatory markers. The mean platelet volume (MPV) is determined in the progenitor cell, the bone marrow megakaryocyte. The platelet volume is found to be associated with cytokines (thrombopoietin, interleukin-6, and interleukin-3) that regulate megakaryocyte ploidy and platelet number and result in the production of larger platelets.

Conditions

Interventions

TypeNameDescription
OTHERCoronary AngiographyCoronary angiograms will be acquired digitally for quantification.
OTHERSYNTAX ScoreUpon retrieval of a version from http://www.syntaxscore.com, the anatomical SYNTAX score will be implemented to numerically evaluate the intricacy of coronary lesions.

Timeline

Start date
2025-01-01
Primary completion
2025-07-10
Completion
2025-07-10
First posted
2025-07-22
Last updated
2026-03-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07076732. Inclusion in this directory is not an endorsement.